Stock Overview
10X Genomics Inc (TXG)
NASDAQ · Healthcare · Health Information Services
10X Genomics Inc is a Healthcare company with a market capitalization of $4.67B.
Market Cap
$4.67B
Forward P/E
625.0
Price/Sales
7.3
Price/Book
5.7
EV/EBITDA
112.1
Beta
2.11
EPS (TTM)
$-0.17
Profit Margin
-3.5%
ROE
-3.0%
52W High
$37.05
52W Low
$11.16
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Revenue
$642.82M
Gross Profit
$443.88M
Operating Income
-$110.89M
Net Income
-$43.54M
Free Cash Flow
$130.12M
Total Debt
$10.98M
Cash & Equivalents
$473.97M
Shareholder Equity
$796.33M
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 7, 2026 | $0.07 | $-0.06 | +216.7% |
| Q4 2025 | February 12, 2026 | $0.07 | $-0.04 | +275.0% |
| Q3 2025 | November 6, 2025 | $-0.02 | $-0.07 | +71.4% |
| Q2 2025 | August 7, 2025 | $0.48 | $-0.08 | +700.0% |
| Q1 2025 | May 8, 2025 | $-0.10 | $-0.29 | +65.5% |
| Q4 2024 | February 12, 2025 | $-0.14 | $-0.11 | -27.3% |
Other Health Information Services Stocks
Frequently Asked Questions
What is 10X Genomics Inc's market cap?
As of June 29, 2026, 10X Genomics Inc (TXG) has a market capitalization of $4.67B.
Does 10X Genomics Inc pay a dividend?
10X Genomics Inc does not currently pay a dividend.
What sector is TXG in?
10X Genomics Inc is in the Healthcare sector, specifically the Health Information Services industry.
What was 10X Genomics Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), 10X Genomics Inc reported revenue of $642.82M and net income of -$43.54M.
Ask your own questions about TXG
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.